Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38%
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nexgel Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Other Liabilities
$1.7m
CAGR 3-Years
42%
CAGR 5-Years
103%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Other Liabilities
$90m
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
10%
ICU Medical Inc
NASDAQ:ICUI
Other Liabilities
$112.8m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
45%
Align Technology Inc
NASDAQ:ALGN
Other Liabilities
$358m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
29%
Lantheus Holdings Inc
NASDAQ:LNTH
Other Liabilities
$85.2m
CAGR 3-Years
-7%
CAGR 5-Years
9%
CAGR 10-Years
8%
Merit Medical Systems Inc
NASDAQ:MMSI
Other Liabilities
$97.5m
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
20%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Other Liabilities?
Other Liabilities
1.7m USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Other Liabilities amounts to 1.7m USD.

What is Nexgel Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
103%

Over the last year, the Other Liabilities growth was 9%. The average annual Other Liabilities growth rates for Nexgel Inc have been 42% over the past three years , 103% over the past five years .

Back to Top